Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2025-12-24 @ 4:36 PM
NCT ID:
NCT04354766
Eligibility Criteria:
Inclusion Criteria:
* Patient over 18 years old
* Patient who signed the study consent form
* Convalescent patient (at least 12 days after the onset of symptoms), having been sampled at Hospices Civils de Lyon for a suspected infection with SARS-Cov-2, confirmed by PCR.
Exclusion Criteria:
* Patient treated with rituximab
* Patient treated with immunoglobulins
* Patient over 18 years old, subject to a legal protection measure (guardianship or trusteeship)
* Patient deprived of liberty
* Pregnant or lactating woman
* Patient not affiliated to a social security scheme or beneficiary of a similar scheme.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04354766
Study Brief:
Protocol Section:
NCT04354766